Drug Shortage Report for VOLIBRIS
| Report ID | 250269 |
| Drug Identification Number | 02307073 |
| Brand name | VOLIBRIS |
| Common or Proper name | ambrisentan tablets |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | AMBRISENTAN |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 1x30 |
| ATC code | C02KX |
| ATC description | OTHER ANTIHYPERTENSIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-02-11 |
| Estimated end date | 2025-02-24 |
| Actual end date | 2025-02-24 |
| Shortage status | Resolved |
| Updated date | 2025-02-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-02-26 | French | Compare |
| v3 | 2025-02-26 | English | Compare |
| v2 | 2025-02-12 | French | Compare |
| v1 | 2025-02-12 | English | Compare |
Showing 1 to 4 of 4